Literature DB >> 16838070

Matriptase: potent proteolysis on the cell surface.

Karin List1, Thomas H Bugge, Roman Szabo.   

Abstract

Matriptase is a type II transmembrane serine protease expressed in most human epithelia, where it is coexpressed with its cognate transmembrane inhibitor, hepatocyte growth factor activator inhibitor (HAI)-1. Activation of the matriptase zymogen requires sequential N-terminal cleavage, activation site autocleavage, and transient association with HAI-1. Matriptase has an essential physiological role in profilaggrin processing, corneocyte maturation, and lipid matrix formation associated with terminal differentiation of the oral epithelium and the epidermis, and is also critical for hair follicle growth. Matriptase and HAI expression are frequently dysregulated in human cancer, and matriptase expression that is unopposed by HAI-1 potently promotes carcinogenesis and metastatic dissemination in animal models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838070      PMCID: PMC1514551          DOI: 10.2119/2006-00022.List

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  48 in total

1.  Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.

Authors:  Pascal Descargues; Céline Deraison; Chrystelle Bonnart; Maaike Kreft; Mari Kishibe; Akemi Ishida-Yamamoto; Peter Elias; Yann Barrandon; Giovanna Zambruno; Arnoud Sonnenberg; Alain Hovnanian
Journal:  Nat Genet       Date:  2004-12-26       Impact factor: 38.330

2.  Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.

Authors:  Ming-Shyue Lee; Ken-ichi Kiyomiya; Christelle Benaud; Robert B Dickson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-08       Impact factor: 4.249

3.  Adhesion signaling by a novel mitotic substrate of src kinases.

Authors:  Ami S Bhatt; Hediye Erdjument-Bromage; Paul Tempst; Charles S Craik; Mark M Moasser
Journal:  Oncogene       Date:  2005-08-11       Impact factor: 9.867

4.  HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.

Authors:  Michael D Oberst; Li-Yuan L Chen; Ken-Ichi Kiyomiya; Cicely A Williams; Ming-Shyue Lee; Michael D Johnson; Robert B Dickson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2005-03-30       Impact factor: 4.249

5.  Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.

Authors:  Roman Szabo; Sarah Netzel-Arnett; John P Hobson; Toni M Antalis; Thomas H Bugge
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

6.  Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia.

Authors:  Jeong-Won Lee; Sang Yong Song; Jung-Joo Choi; Sun-Joo Lee; Byoung-Gie Kim; Chang-Soo Park; Je-Ho Lee; Chen-Yong Lin; Robert B Dickson; Duk-Soo Bae
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

7.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes.

Authors:  John P Hobson; Sarah Netzel-Arnett; Roman Szabo; Sophie M Réhault; Frank C Church; Dudley K Strickland; Daniel A Lawrence; Toni M Antalis; Thomas H Bugge
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

9.  Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues.

Authors:  A C P Riddick; C J Shukla; C J Pennington; R Bass; R K Nuttall; A Hogan; K K Sethia; V Ellis; A T Collins; N J Maitland; R Y Ball; D R Edwards
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.

Authors:  H Tanimoto; K Shigemasa; X Tian; L Gu; J B Beard; T Sawasaki; T J O'Brien
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

View more
  56 in total

1.  Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.

Authors:  Abdo J Najy; Joshua J Won; Lisa S Movilla; Hyeong-Reh C Kim
Journal:  Mol Cancer Res       Date:  2012-06-11       Impact factor: 5.852

Review 2.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

3.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

4.  Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase.

Authors:  Lina Basel-Vanagaite; Revital Attia; Akemi Ishida-Yamamoto; Limor Rainshtein; Dan Ben Amitai; Raziel Lurie; Metsada Pasmanik-Chor; Margarita Indelman; Alex Zvulunov; Shirley Saban; Nurit Magal; Eli Sprecher; Mordechai Shohat
Journal:  Am J Hum Genet       Date:  2007-01-23       Impact factor: 11.025

5.  Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.

Authors:  Jehng-Kang Wang; Ming-Shyue Lee; I-Chu Tseng; Feng-Pai Chou; Ya-Wen Chen; Amy Fulton; Herng-Sheng Lee; Cheng-Jueng Chen; Michael D Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-17       Impact factor: 4.249

6.  Sampling the N-terminal proteome of human blood.

Authors:  David Wildes; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-19       Impact factor: 11.205

7.  Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.

Authors:  Manisha Tripathi; Alka A Potdar; Hironobu Yamashita; Brandy Weidow; Peter T Cummings; Daniel Kirchhofer; Vito Quaranta
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

8.  Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities.

Authors:  Brian S Hamilton; David W J Gludish; Gary R Whittaker
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

9.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

10.  A sequence and structure based method to predict putative substrates, functions and regulatory networks of endo proteases.

Authors:  Prasanna Venkatraman; Satish Balakrishnan; Shashidhar Rao; Yogesh Hooda; Suyog Pol
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.